Operating Expenses
Goodwill and indefinite-lived intangible asset impairment
Edwards Lifesciences Goodwill and indefinite-lived intangible asset impairment increased by 162.4% to $123.60M in Q1 2026 compared to the prior quarter.
Analysis
StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2020
Last reportedQ1 2026May 6, 2026
Metric ID:
pg_goodwill_and_indefinite_lived_intangible_asset_impairmentHistorical Data
12 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '23 | Q2 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $1.00M | $1.00M | $13.78M | $13.78M | $13.78M | $13.78M | $0.00 | $0.00 | $0.00 | $47.10M | $123.60M |
| QoQ Change | — | +0.0% | +0.0% | >999% | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — | +162.4% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | -100.0% | — | — | — | — |
Range$0.00 – $123.60M
CAGR+476.4%
Avg YoY Growth+933.1%
Median YoY Growth>999%
Goodwill and indefinite-lived intangible asset impairment at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's goodwill and indefinite-lived intangible asset impairment?
- Edwards Lifesciences (EW) reported goodwill and indefinite-lived intangible asset impairment of $123.60M in Q1 2026.